Pancreatic Cancer Research

ResearcherSheng Jing HospitalNo recent work listed

Lu Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1920-4965; OpenAlex author ID A5100386314. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper

Papers 3

  1. CHST12: a potential prognostic biomarker related to the immunotherapy response in pancreatic adenocarcinoma. First author DOI 10.3389/fendo.2023.1226547↗
  2. The Clinical Diagnostic Value of F-FDG PET/CT Combined with MRI in Pancreatic Cancer. Last author DOI 10.1155/2022/1479416↗
  3. Analysis of dynamic molecular networks for pancreatic ductal adenocarcinoma progression. First author DOI 10.1186/s12935-018-0718-5↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guang Han · 1 shared paper, 2023 · strength 0.31
  2. Kun Liu · 1 shared paper, 2023 · strength 0.31
  3. Xinyan Liu · 1 shared paper, 2022 · strength 0.20
  4. Zongfu Pan · 1 shared paper, 2018 · strength 0.09
  5. Ping Huang · 1 shared paper, 2018 · strength 0.09
  6. Yiwen Zhang · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.